New Hevolution Foundation Scientific Advisory Panel set to leverage geroscience expertise

Foundation announces experts that will guide Hevolution’s geroscience and healthspan research program.

Hevolution Foundation, the Saudi-based non-profit that provides grants and early-stage investments to incentivize research and entrepreneurship in healthspan science, has formed a Scientific Advisory Panel (SAP).

Longevity.Technology: An independent panel, the SAP will serve a purely advisory role, and its goal is to enrich Hevolution’s engagement with the scientific community and help the organization to enhance and validate its strategy and scientific initiatives

Hevolution’s new SAP members will be providing input, guidance and support for Hevolution’s efforts to fund top healthspan research and geroscience worldwide. To that end, it is no surprise that the Foundation has brought together several experts in aging and geroscience research to help it meet its goals – and it’s a roster of names that will be familiar to our readers.

“It is a true honor to welcome such an esteemed panel of scientists to an advisory role at Hevolution Foundation,” commented Felipe Sierra, PhD, Chief Scientific Officer of Hevolution Foundation and Chairman of the SAP.

“Made up of some of the most pre-eminent leaders in aging-related research, drawn from three continents, the Hevolution Foundation SAP will provide strategic counsel and validate our progress. We look forward to input and guidance from these outstanding individuals as we progress in our efforts to extend healthy human lifespan and understand the processes of aging.”

Founding members of Hevolution’s Scientific Advisory Panel include:

Brian Kennedy, PhD. Based in Singapore, Kennedy is a Distinguished Professor in Biochemistry and Physiology at the Yong Loo Lin School of Medicine at National University Singapore (NUS) and serves as Director of (1) the Centre for Healthy Longevity at the National University Health System in Singapore, (2) the NUS Medicine Healthy Longevity Translational Research Programme and (3) the Asia Centre for Reproductive Longevity and Equality at the NUS School of Medicine. He was formerly President and CEO of the Buck Institute for Research on Aging and served as a professor there through 2020. Additionally, Kennedy serves as a Co-Editor-In-Chief at Aging Cell, the peer-reviewed scientific journal.

Guido Kroemer, MD, PhD. Based in France, Kroemer is Professor at the Faculty of Medicine at Université Paris Cité, Director of the research team “Metabolism, Cancer and Immunity” of the French National Institute for Health and Medical Research (INSERM), Director of the Metabolomics and Cell Biology platforms at the Gustave Roussy Comprehensive Cancer Campus in Paris and Hospital Practitioner at the Hôpital Européen George Pompidou, Paris. He is President of the European Academy of Tumor Immunology (EATI), and director of LabEx Immuno-Oncology, a research consortium. In addition, Kroemer is also the founding editor of six journals, including Cell Death & Disease (Nature Publishing Group, Springer).

Andrea Maier, MD, PhD. Based in Singapore, Maier is Longevity Medicine Physician and Oon Chiew Seng Professor in Medicine, Healthy Ageing and Dementia Research, and Director of the Centre for Healthy Longevity at National University of Singapore, as well as Professor of Gerontology at Vrije Universiteit Amsterdam (the Netherlands). She was previously head of Geriatrics at the Vrije Universiteit Medical Center in Amsterdam, and before that Maier served as Divisional Director of Medicine and Community Care at the Royal Melbourne Hospital, Australia, and Professor of Medicine and Aged Care at the University of Melbourne. Maier is also Founding President of the Healthy Longevity Medicine Society and serves as a selected Member of The Royal Holland Society of Sciences and Humanities and advisor to the World Health Organization evaluating the United Nations Decade of Healthy Ageing.

Laura Niedernhofer, MD, PhD. Based in the US, Niedernhofer is Professor of Biochemistry, Molecular Biology, and Biophysics and Director of the Institute on the Biology of Aging and Metabolism (iBAM) at University of Minnesota. She was formerly Associate Professor of Molecular Medicine at the Florida campus of Scripps Research Institute and before that was Associate Professor of Microbiology and Molecular Genetics at University of Pittsburgh. Niedernhofer is a recipient of a Glenn Award for Research in Biological Mechanisms of Aging, and the Vincent Cristofalo Rising Star Award in Aging Research from American Federation for Aging Research (AFAR).

Thomas Rando, MD, PhD. Based in the US, Rando is Director of the Broad Stem Cell Research Center at the University of California, Los Angeles (UCLA) and Professor of Neurology and Molecular, Cell and Developmental Biology at UCLA. Formerly, he was a Professor, Department of Neurology and Neurological Sciences at Stanford University School of Medicine. At Stanford, Rando was Director of the Glenn Center for Biology of Aging Research and Deputy Director, Stanford Center on Longevity. Recipient of the US National Institutes of Health Director’s Pioneer Award, Rando has also received, among other awards, a Transformative R01 based on his work in stem cell biology and the biology of aging. Rando is a member of the US National Academy of Medicine and the American Academy of Arts and Sciences.